)
Astrazeneca's China pill: Remedy for business?
AstraZeneca is reportedly planning to separate its China business and list it separately in Hong Kong or Shanghai. This move aims to help the company secure its presence in China and protect itself from potential geopolitical risks.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)